SCHEMBL1847416

SCHEMBL1847416

O=C(O)N(F)c1cccc(C(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 1/20 0.50
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ MAPT P10636 2/20 0.46
▸ SRD5A2 P31213 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ MGLL Q99685 1/20 0.46
▸ MPO P05164 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ AKR1C3 P42330 1/20 0.43
▸ AKR1C2 P52895 1/20 0.43
▸ CETP P11597 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ MAOB P27338 1/20 0.42
▸ KCNK3 O14649 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9835938 0.84 CES2 (0.49) CES2MEN1KMT2AMAPTSRD5A2
SCHEMBL11174926 0.81 TACR1 (0.50) CES2MEN1KMT2AMAPTSRD5A2
SCHEMBL1013242 0.81 CES2 (0.49) CES2MEN1KMT2AMAPTSRD5A2
SCHEMBL2094545 0.81 MEN1 (0.49) CES2MEN1KMT2AMAPTSRD5A2
SCHEMBL1703719 0.81 CES2 (0.49) CES2MEN1KMT2AMAPTSRD5A2
SCHEMBL7592350 0.78 TSHR (0.52) CES2MEN1KMT2AMAPTMGLL
SCHEMBL23636332 0.78 TP53 (0.48) CES2MEN1KMT2AMAPTSRD5A2
SCHEMBL440958 0.78 RXFP1 (0.43) CES2MAPTMGLLLMNATP53
SCHEMBL20560278 0.77 MGLL (0.44) CES2MEN1KMT2AMAPTMGLL
SCHEMBL28102660 0.77 CES2 (0.48) CES2SRD5A2RAB9AMGLLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2324029-A2 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE Kalypsys, Inc. (US) 2011-05-25 — — EP disclosed
WO-2010030785-A2 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE KALYPSYS INC. (US) 2010-03-18 — — WO disclosed
Send feedback